Effect of topical cream of Gracilaria algae in treatment of plaque type Psoriasis

Design, Formulation, physicochemical evaluation and clinical trial of Gracilaria algae topical cream for treatment of plaque type Psoriasis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191112045423N1

Enrollment

Registered

2020-01-31

Start date

2019-12-14

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque type Psoriasis. Other psoriasis

Interventions

Intervention 1: Intervention group: gracilaria algae topical cream 3% which is made in Dr.Shahtalebi laboratory in Isfahan,once daily for 2 months,topical,one of the symmetric plaques in each patients

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Mild to moderate plaque type psoriasis include atleast 2 symetric plaques involvement of less than 20 percent of body surface age limitation between 20 to 60 years old free and informed written consent for participating in study

Exclusion criteria

Exclusion criteria: Pregnancy Lactation Renal Failure Hepatitis and Liver Failure Concurrent systemic treatment indication

Design outcomes

Primary

Measure	Time frame
PASI(psoriasis area and severity index). Timepoint: 4 and 8 weeks after using creams. Method of measurement: Dermatologist opinion based on PASI score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad ali shahtalebi

Esfahan University of Medical Sciences

shatalebi@pharm.mui.ac.ir+98 31 3792 7001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026